Literature DB >> 2019172

Empyema thoracis. Factors influencing morbidity and mortality.

D G Ashbaugh1.   

Abstract

The effects of delay in surgical treatment and the choice of operation on morbidity associated with empyema thoracis were evaluated in 122 consecutive patients. Patients (71 from a private practice and 51 from an inner-city trauma/indigent care facility) eligible for study were divided into treatment groups of chest tube only (CT = 39) and open drainage (OD = 19), or decortication (DC = 65). Delay in treatment was defined as greater than 3 days from recognition of empyema to CT and greater than 14 days to OD or DC when chest tubes were inadequate or were not used initially. Delay in OD significantly increased total illness (p = 0.023), days until removal of chest tubes (p = 0.037), and hospital stay (p = .048), but did not affect postoperative stay. Delay in DC increased total illness (p = 0.0001), but did not affect other variables. Delay in CT increased mortality from 3.4 percent to 16 percent. Delay did not increase mortality in OD and DC. DC was superior to OD in patients requiring major operation in total illness days (DC = 36.1 vs OD = 106.1) (p = 0.0005), days until removal of tubes (DC = 7.5 vs OD = 78.3) (p = 0.0001), and postoperative stay (DC = 11.6 vs OD = 17.3) (p = 0.018). Overall mortality was lowest in the DC group (6.1 percent). Delay in treatment increases morbidity and DC is more effective than OD in reducing morbidity and mortality when surgical intervention is necessary.

Entities:  

Mesh:

Year:  1991        PMID: 2019172     DOI: 10.1378/chest.99.5.1162

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  25 in total

1.  BTS guidelines for the management of pleural infection.

Authors:  C W H Davies; F V Gleeson; R J O Davies
Journal:  Thorax       Date:  2003-05       Impact factor: 9.139

2.  68-year-old man with chronic cough and weight loss.

Authors:  Megan M Dulohery; Furman S McDonald
Journal:  Mayo Clin Proc       Date:  2010-06       Impact factor: 7.616

3.  Procalcitonin as preoperative marker for surgery in advanced parapneumonic empyema.

Authors:  Claudio Caviezel; Philipp Schuetz; Stephan Gerdes; Franco Gambazzi
Journal:  J Thorac Dis       Date:  2017-03       Impact factor: 2.895

4.  Rapidly progressive paraplegia and pleural empyema: how does that correlate?

Authors:  Mario Lescan; Guilherme Lepski; Volker Steger; Christian Schlensak; Tobias Walker
Journal:  Gen Thorac Cardiovasc Surg       Date:  2012-12-30

5.  Benefits of using omental pedicle flap over muscle flap for closure of open window thoracotomy.

Authors:  Shuichi Shinohara; Yasuhiro Chikaishi; Taiji Kuwata; Masaru Takenaka; Soichi Oka; Ayako Hirai; Naoko Imanishi; Koji Kuroda; Fumihiro Tanaka
Journal:  J Thorac Dis       Date:  2016-07       Impact factor: 2.895

6.  Emergence of parapneumonic empyema in the USA.

Authors:  Carlos G Grijalva; Yuwei Zhu; J Pekka Nuorti; Marie R Griffin
Journal:  Thorax       Date:  2011-05-26       Impact factor: 9.139

7.  Decortication for chronic parapneumonic empyema: results of a prospective study.

Authors:  Giulio Melloni; Angelo Carretta; Paola Ciriaco; Giampiero Negri; Carlopietro Voci; Giuseppe Augello; Piero Zannini
Journal:  World J Surg       Date:  2004-04-19       Impact factor: 3.352

8.  Empyema thoracis.

Authors:  Ala Eldin H Ahmed; Tariq E Yacoub
Journal:  Clin Med Insights Circ Respir Pulm Med       Date:  2010-06-17

9.  Empyema: an increasing concern in Canada.

Authors:  Christian Finley; Joanne Clifton; J Mark Fitzgerald; John Yee
Journal:  Can Respir J       Date:  2008-03       Impact factor: 2.409

10.  Empyema thoracis: a clinical study.

Authors:  Preetam Rajgopal Acharya; Kusum V Shah
Journal:  Ann Thorac Med       Date:  2007-01       Impact factor: 2.219

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.